Humana Prior Authorization Denial Appeal 2026: EviCore Routing & P2P Guide

Why Humana PA Denials Require a Different Appeal Approach

Humana is the second-largest Medicare Advantage insurer in the United States, with over 17 million members — more than 85% enrolled in Medicare Advantage or Part D. For most independent practices, this means Humana PA denials are concentrated in Medicare Advantage cases, where federal timelines under CMS-0057-F, a delegated specialty review model, and a five-level CMS appeal ladder all operate differently from commercial plans.

The single most common error in Humana PA appeals is treating every denial as a Humana appeal. Humana contracts with third-party utilization management vendors to administer PA decisions for specific service categories. When those entities issue a denial, the appeal — including the peer-to-peer review request — must go to them, not to Humana's central appeals department. Filing to the wrong entity does not pause the P2P window; it consumes it.

The 2026 regulatory changes that most directly affect Humana PA appeals:

• CMS-0057-F (effective January 1, 2026): Humana Medicare Advantage plans must now issue PA decisions within 7 calendar days (standard) or 72 hours (expedited) and provide patient-specific clinical denial reasons — not generic policy number references.
• CMS-4208-F: Prohibits retroactive reversal of prior-authorized inpatient admissions once the patient is admitted. Concurrent determination rights apply if Humana attempts to reverse an approved admission mid-stay.
• PA reductions (January 1, 2026): Humana eliminated approximately one-third of outpatient PA requirements, including colonoscopies, transthoracic echocardiograms, and select CT and MRI scans.
• Gold card program (2026 launch): Qualifying providers with consistent quality outcomes may have PA requirements waived for eligible service categories. Contact your Humana provider relations representative for enrollment eligibility.

For a broader overview of how to handle all Humana denial types — including timely filing, coding errors, and corrected claims — see the how to appeal Humana denials guide.

How to Identify Who Denied Your Humana PA

Read the first two lines of the denial letter before calling anyone. The issuing entity's name and a case reference number format tell you everything you need to know about where the appeal goes.

EviCore by Evernorth denial: The letter prints on EviCore letterhead and includes an EviCore case reference number with an "EVC-" prefix. The mailing address, phone number, and fax on the denial route to EviCore — not to Humana. The appeal rights section cites EviCore's appeal procedures and deadlines.

Evolent Health denial: The letter carries Evolent letterhead and references an Evolent case number. Evolent manages Humana's oncology PA program; the denial letter will include Evolent contact information for peer-to-peer requests and formal appeals.

Humana internal UM denial: The letter shows Humana's name, a Humana-formatted case reference number, and directs submissions to Resolutions.Humana.com or Humana's mailing address in Lexington, KY.

EviCore-Managed Humana PA Denials

EviCore by Evernorth manages specialty prior authorization for Humana across multiple high-volume categories. For many Humana commercial and Medicare Advantage plans, the services delegated to EviCore include cardiology, advanced imaging (CT, MRI, CTA, MRA), musculoskeletal procedures, radiology, oncology, and neurology.

EviCore enforces a 7-calendar-day window from the denial date to request peer-to-peer review. This window is strict and is not prominently labeled in most denial letters — billing teams often see the 30-day formal appeal deadline and assume they have 30 days for everything. The P2P window is separate, shorter, and far more valuable: peer-to-peer review overturns a higher proportion of denials than written appeals for most service categories.

How to Request Peer-to-Peer Review for an EviCore-Managed Denial

Request peer-to-peer review through the EviCore provider portal at evicore.com/provider, or by phone at 800-646-0418, option 2. The ordering physician — not a billing staff member — must initiate the P2P call. EviCore typically schedules calls within 24–72 hours, and the review itself usually runs 5–10 minutes.

Under CMS-0057-F (effective January 1, 2026), EviCore-managed Humana Medicare Advantage PA denials must specify the exact clinical criterion used and explain why the patient did not meet it. Before the P2P call, identify that criterion from the denial letter and prepare talking points that directly address it — presenting a general clinical argument without addressing the cited gap is the most common reason P2P calls fail to reverse a denial.

Filing a Formal EviCore Appeal

If the peer-to-peer review does not result in reversal, file the formal appeal through the EviCore provider portal at evicore.com/provider. Include:

• The original denial letter and EviCore case reference number (EVC- prefix)
• Physician-signed letter of medical necessity citing the specific clinical criterion from the denial notice
• Medical records covering the relevant treatment history
• Published guideline citations supporting the requested service
• Completed EviCore appeal form (available at evicore.com/provider)

EviCore issues appeal decisions within 30 calendar days of a complete submission, or on a shorter state-specific timeline. If EviCore upholds the denial, the next escalation is Humana's appeals process.

Evolent Health: Humana's Oncology PA Partner

Evolent Health manages prior authorization for oncology services under Humana's expanded partnership announced in November 2024. Following that agreement, Evolent's scope under Humana grew to include radiation oncology and surgical oncology services, extending what had previously been a more limited arrangement.

For practices treating cancer patients under Humana coverage, Evolent-issued PA denials follow the same general pattern as EviCore denials: the denial letter shows Evolent letterhead with Evolent contact information, and the peer-to-peer request must go to the Evolent provider portal — not to Humana or EviCore.

If a formal Evolent appeal is upheld (denial maintained), the case escalates to Humana's standard appeals process.

Humana Internal UM: Prior Authorization Appeals for Non-Delegated Services

For services not managed by EviCore or Evolent, the appeal goes directly to Humana's internal utilization management team. This includes inpatient admissions for many plan types, behavioral health services not covered by a separate carve-out vendor, and any service category not listed in the delegation notice for a specific plan.

Requesting Peer-to-Peer Review Through Humana

Request peer-to-peer review through Availity Essentials (Humana's preferred portal) or by calling Humana Provider Services at 800-457-4708. Humana typically schedules P2P calls within 3–5 business days. The P2P request should be made within 7 days of the initial denial.

Filing a Formal Appeal with Humana

Submit formal appeals through Resolutions.Humana.com (preferred for tracking) or mail to:

Humana Grievances and Appeals
P.O. Box 14546
Lexington, KY 40512-4546

For expedited Medicare Advantage appeals, call 800-867-6601.

Medicare Advantage vs Commercial: Different Deadlines, Different Appeal Ladders

The appeal path after denial differs significantly between Humana Medicare Advantage and commercial plans. Applying the commercial deadline to an MA denial — or treating the CMS appeal ladder as optional — are two of the most expensive process errors in Humana billing.

Medicare Advantage Appeal Ladder

The CMS Part C five-level appeal ladder applies to all Humana Medicare Advantage PA denials:

1. Level 1 — Organization Determination: Humana (or the delegated vendor) issues the initial denial. Submit your appeal within 65 calendar days.
2. Level 2 — Independent Review Entity: If Humana upholds the Level 1 denial, it must automatically forward the case to MAXIMUS Federal Services (the current CMS-contracted IRE, reachable at 1-888-734-5579). You do not re-file — Humana forwards the case.
3. Level 3 — ALJ Hearing: Available when the amount in controversy is at least $180 (2026 threshold). Must be filed within 60 days of the IRE decision.
4. Level 4 — Medicare Appeals Council (MAC): Administrative review of the ALJ decision.
5. Level 5 — Federal District Court: Judicial review when the amount in controversy meets the threshold (approximately $1,870 for 2026).

Peer-to-Peer Review: The Highest-Yield Step After Any Humana PA Denial

Peer-to-peer review should always come before a written appeal. The ordering physician speaks directly with the reviewing clinician — either the EviCore, Evolent, or Humana medical director who made the initial determination — to present clinical context that may not have been available or legible in the original PA submission.

Three things that improve P2P success rates:

1. Address the denial criterion directly. CMS-0057-F now requires Humana MA denials to cite the specific clinical criterion used and explain why the patient did not meet it. Read that criterion before the call and prepare a structured response — treating the P2P call as a general argument rather than a targeted rebuttal is the most common reason P2P fails to reverse.

2. The ordering physician should conduct the call. Delegating the P2P to billing staff or a nurse coordinator reduces effectiveness. Reviewing medical directors respond to clinical dialogue, not administrative follow-up.

3. Request P2P on the same day you receive the denial. The 7-day window runs from the denial date, not from when you open the letter. A same-day triage review of all incoming Humana denials — with immediate P2P scheduling for any clinical denial — protects the window.

Documentation Package for Humana PA Appeals

A complete Humana PA appeal submission includes the following regardless of which entity manages the case:

Humana PA Appeal Documentation Checklist

Required for all submissions:
□ Original denial letter with case reference number
□ Ordering physician's signed letter of medical necessity
   — must cite the specific Humana MCP (or EviCore/Evolent guideline) number
   — must address the specific criterion cited in the denial
□ Relevant medical records (treatment history, test results, clinical notes)
□ Clinical guideline citations from recognized medical societies or CMS guidance
□ Patient's diagnosis with ICD-10 code(s)
□ CPT/HCPCS codes for the requested service

For Medicare Advantage PA denials (CMS-0057-F):
□ Patient-specific clinical reason from denial letter (required as of Jan 1, 2026)
□ Plan type identifier (AARP MedicareComplete, Dual Complete, Group MA, etc.)
□ For expedited: documentation of why delay would seriously jeopardize health

For EviCore-managed submissions:
□ EVC- case reference number on all documents
□ Completed EviCore appeal form (evicore.com/provider)

For Evolent-managed submissions:
□ Evolent case reference number on all documents
□ Completed Evolent appeal form from the Evolent provider portal

How Muni Appeals Handles Humana PA Denials

Humana PA appeals involve routing decisions, deadline tracking across plan types, and clinical documentation that has to match the specific policy language — not generic medical necessity language. Billing teams that handle this manually spend significant time on coordination that should be systematic.

Muni Appeals supports Humana PA denial workflows across:

• Delegation routing identification (EviCore vs Evolent vs internal UM) from denial letter analysis
• P2P scheduling triage with same-day flagging for denials within the 7-day window
• Humana Medical Coverage Policy look-up and citation in appeal letters
• MA vs commercial deadline tracking with automatic 65-day and 180-day flags
• Submission through Resolutions.Humana.com, evicore.com/provider, and Availity

Start Free Trial

Frequently Asked Questions

How long do I have to appeal a Humana Medicare Advantage PA denial?

You have 65 calendar days from the date of the denial notice to file a Level 1 appeal with Humana for Medicare Advantage plans. This is shorter than the 180-day commercial appeal window, and billing teams that apply the commercial deadline to MA denials routinely miss the cutoff permanently. Calendar from the denial letter date, not the date you received it.

What is the difference between EviCore and Humana NAU for PA appeals?

EviCore by Evernorth is a third-party utilization management vendor that Humana has contracted to manage specialty PA for cardiology, imaging, MSK, radiology, oncology, and neurology across many plans. When EviCore issues the denial, you appeal to EviCore — not to Humana's central appeals department. Filing to the wrong entity results in a routing delay or procedural rejection. Humana's internal UM team (the unit that handles non-delegated services) is separate and uses a different submission path: Availity or Resolutions.Humana.com.

Can I request expedited peer-to-peer review for urgent Humana cases?

Yes. For Humana Medicare Advantage plans, an expedited PA determination is available when a standard timeline would seriously jeopardize the patient's health, life, or ability to regain maximum function. The expedited track requires a 72-hour decision under CMS-0057-F. Call Humana's expedited review line at 800-867-6601 and state that you are requesting an expedited determination. The 72-hour clock begins when Humana receives the request.

Does the 7-day P2P window apply to Humana commercial PA denials as well?

Humana publishes a 7-day peer-to-peer review request window for clinical denials across both commercial and Medicare Advantage plans, per its provider manual and EviCore's published procedures. In practice, treat 7 days as the effective window regardless of plan type — filing P2P requests later reduces the likelihood of scheduling the call before the formal appeal deadline passes.

What clinical standard does Humana use for PA appeals?

Humana uses its own Medical Coverage Policies (MCPs) as the clinical standard for commercial and Medicare Advantage plans — not InterQual, MCG, or the criteria published by other payers. The specific MCP governing a denied service is available at provider.humana.com. Every appeal letter should cite the MCP number, revision date, and the applicable criteria. Appeals citing InterQual or generic medical necessity language give the reviewer no reason to reverse the denial.

What happens if Humana upholds my Level 1 Medicare Advantage PA appeal?

If Humana upholds the denial at Level 1, it must automatically forward your case to the Independent Review Entity (IRE) — currently MAXIMUS Federal Services (1-888-734-5579) — for Level 2 reconsideration. You do not need to re-file with MAXIMUS; Humana is required to forward the case. MAXIMUS must issue its determination within 60 days for standard reconsideration or 72 hours for expedited. If MAXIMUS also upholds the denial, you can escalate to a Level 3 ALJ hearing if the amount in controversy is at least $180 (2026 threshold).

How do I identify which Humana plan type a patient has to route the appeal correctly?

The plan type is printed on the patient's Humana member ID card and on the Explanation of Benefits (EOB) header. AARP MedicareComplete, Humana Gold Plus HMO, Humana Preferred PPO, and Humana Choice PPO are Medicare Advantage plans subject to the 65-day deadline and CMS appeal ladder. Humana Gold, Humana PPO, and employer group plan names indicate commercial coverage with the 180-day deadline. When in doubt, call Humana Provider Services at 800-457-4708 and ask to confirm the plan type and applicable appeal deadline before filing.

Ready to Stop Losing Humana PA Appeals to Routing Errors?

Humana's delegation model means that getting the appeal path right is not optional — it determines whether the P2P window stays open. Practices that triage Humana denials systematically, route to the correct entity on the day of denial, and cite Humana's own Medical Coverage Policies recover more denials than those that treat every Humana case as a standard appeal.

Get Started:

• Same-day P2P scheduling triage for Humana denials within the 7-day window
• Delegation routing identification (EviCore, Evolent, or Humana UM) from denial letter
• Humana Medical Coverage Policy citation built into every appeal letter
• 65-day and 180-day deadline tracking by plan type

Start Free Trial

---

This guide reflects 2026 Humana prior authorization and appeal procedures, including CMS-0057-F and CMS-4208-F requirements effective January 1, 2026. Delegation arrangements, appeal deadlines, and clinical policy standards may vary by Humana plan type, geographic market, and employer plan document. Muni Appeals maintains current Humana-specific workflows for commercial and Medicare Advantage plans. For Medicaid managed care plan details, consult the applicable state plan contract.